Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Makoto Imori
Observed names:
Imori, Makoto,
MAKOTO IMORI
Institution:
Eli Lilly (Japan)
Observed institutions:
Kyoto University,
Eli Lilly (Japan)
OpenAlex ID:
A5076145238
Ultra‐Rapid Lispro results in accelerated insulin lispro absorption and faster early insulin action in comparison with Humalog® in Japanese patients with type 1 diabetes
2019
·
Masanari Shiramoto
, Risa Nasu
, et al.
·
Journal of Diabetes Investigation
·
21
PDF
Efficacy and safety of growth hormone replacement therapy in Japanese adults with growth hormone deficiency: a post-marketing observational study
2013
·
Akira Shimatsu
, Shigeru Tai
, et al.
·
Endocrine Journal
·
20
PDF
Ultra-Rapid Lispro Efficacy and Safety Compared to Humalog® in Japanese Patients with Type 1 Diabetes: PRONTO-T1D Subpopulation Analysis
2020
·
Junnosuke Miura
, Makoto Imori
, et al.
·
Diabetes Therapy
·
12
PDF
Impact of diet on the efficacy of insulin lispro mix 25 and insulin lispro mix 50 as starter insulin in East Asian patients with type 2 diabetes: Subgroup analysis of the Comparison Between Low Mixed Insulin and Mid Mixed Insulin as Starter Insulin For Patients with Type 2 Diabetes Mellitus ( CLASSIFY Study) randomized trial
2016
·
Wei Chen
, Lei Qian
, et al.
·
Journal of Diabetes Investigation
·
8
PDF
Pharmacokinetic and Pharmacodynamic Properties of Once-Weekly Insulin Efsitora Alfa in Japanese Patients with Type 2 Diabetes
2025
·
Risa Nasu
, Tomonori Oura
, et al.
·
Diabetes Therapy
·
6
PDF
CCAAT/enhancer binding protein α maintains the ability of insulin-stimulated GLUT4 translocation in 3T3-C2 fibroblastic cells
2005
·
Muneya Fujimoto
, Hiroaki Masuzaki
, et al.
·
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
·
5
PDF
Therapy-Related Satisfaction and Quality of Life for Japanese People with Diabetes Using Rapid-Acting Insulin Analogs: A Web-Based Survey
2024
·
Hitoshi Ishii
, Yasutaka Maeda
, et al.
·
Diabetes Therapy
·
4
Determinants and impact of physical impairment in patient-reported outcomes among older patients with type 2 diabetes mellitus in Japan
2020
·
Atsushi Araki
, Hiroyuki Umegaki
, et al.
·
Current Medical Research and Opinion
·
4
Investigation of Severe Hypoglycemia Risk Among Patients with Diabetes Treated with Ultra-Rapid Lispro in Japan
2024
·
Seiko Mizuno
, Machiko Minatoya
, et al.
·
Advances in Therapy
·
3
PDF
Validation study of case-identifying algorithms for severe hypoglycemia using hospital administrative data in Japan
2023
·
Satoshi Osaga
, Takeshi Kimura
, et al.
·
PLoS ONE
·
3
PDF
Ultra-Rapid Lispro Efficacy and Safety Compared to Humalog® in Japanese Patients With Type 2 Diabetes: PRONTO-T2D Subpopulation Analysis
2020
·
Hideaki Jinnouchi
, Makoto Imori
, et al.
·
Diabetes Therapy
·
3
PDF
Open‐label, randomized study comparing basal insulin peglispro and insulin glargine, in combination with oral antihyperglycemic medications, in insulin‐naïve Asian patients with type 2 diabetes
2017
·
Takahisa Hirose
, Zhihong Cai
, et al.
·
Journal of Diabetes Investigation
·
3
PDF
Long-term Efficacy and Safety of Ultra Rapid Lispro in Japanese Patients With Type 1 Diabetes: Subpopulation Analysis of the 52-Week PRONTO-T1D Study
2021
·
Junnosuke Miura
, Hiroshi Nishiyama
, et al.
·
Diabetes Therapy
·
2
PDF
Insulin lispro 25/75 and insulin lispro 50/50 as starter insulin in Japanese patients with type 2 diabetes: subanalysis of the CLASSIFY randomized trial
2017
·
Hirotaka Watada
, Makoto Imori
, et al.
·
Endocrine Journal
·
2
PDF
Correction: Investigation of Severe Hypoglycemia Risk Among Patients with Diabetes Treated with Ultra-Rapid Lispro in Japan
2026
·
Seiko Mizuno
, Machiko Minatoya
, et al.
·
Advances in Therapy
·
1
802-P: Safety, Pharmacokinetics, and Pharmacodynamics of Once-Weekly Basal Insulin Fc (BIF) in Japanese Patients with Type 2 Diabetes: A Phase 1 Open-Label, Randomized, Active-Controlled Trial
2022
·
RISA NASU
, TOMONORI OURA
, et al.
·
Diabetes
·
1
742-P: Phase 1 Study of Safety, Tolerability, PK, and PD of Once-Weekly Basal Insulin Fc (BIF) in Japanese Patients with T2DM
2021
·
KENJI OHWAKI
, KENICHI FURIHATA
, et al.
·
Diabetes
·
1
日本人T1DM患者でUltra Rapid Lispro(URLi)はヒューマログと比べてインスリンリスプロの吸収と作用発現がより早期にシフトする
2019
·
Masanari Shiramoto
, Risa Nasu
, et al.
·
Tōnyōbyō/Tounyoubyou
Show more works
View as search
Works count:
22
Citation count:
99
H-index:
5
I10-index:
3
Year
Topic
Type